![](/img/cover-not-exists.png)
Pasireotide (SOM230): a novel pituitary-targeted medical therapy for the treatment of patients with Cushing’s disease
Moloney, Kelley J, Mercado, Jennifer U, Ludlam, William H, Mayberg, Marc RVolume:
7
Language:
english
Journal:
Expert Review of Endocrinology & Metabolism
DOI:
10.1586/eem.12.49
Date:
September, 2012
File:
PDF, 6.99 MB
english, 2012